All terms in BAO
| Label | Id | Description |
|---|---|---|
| RNA interference construct | BAO_0002149 | |
| dentin sensitivity | DOID_698 | |
| abdominal tuberculosis | DOID_0050599 | [An extrapulmonary tuberculosis that is located_in gastrointestinal tract, located_in peritoneum, located_in omentum, located_in mesentery, located_in liver, located_in spleen or located_in pancreas.] |
| activity threshold signal direction | BAO_0002141 | [The direction of the readout signal, relative to negative controls, which is considered to be of interest for determining active perturbagents (hits).] |
| activity threshold specification | BAO_0002140 | |
| tuberculosis | DOID_399 | [A primary bacterial infectious disease that is located_in lungs, located_in lymph nodes, located_in pericardium, located_in brain, located_in pleura or located_in gastrointestinal tract, has_material_basis_in Mycobacterium tuberculosis, which is transmitted_by droplets released into the air when an infected person coughs or sneezes.] |
| glycogen storage disease IV | DOID_2750 | |
| glycogen storage disease | DOID_2747 | [A glycogen metabolism disorder that has_material_basis_in enzymes deficiencies necessary in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types.] |
| robust z-prime factor | BAO_0002143 | [A parameter defining the separation of the noise bands of the negative and positive controls in an experiment using robust statistics. The robust z' is defined as 1-(3*(MAD(pos)-MAD(neg))/abs(median(pos)-median(neg)) where MAD(pos) is the median absolute deviation of the positive control population and MAD(neg) is the median absolute deviation of the negative control population. Typically defined on a per-plate basis but may be defined for an overall assay.] |
| IC90 | BAO_0002144 | [The effective concentration of an inhibitor, which produces 90% of the maximum possible response for that inhibitor.] |
| glycogen storage disease II | DOID_2752 | [A glycogen storage disease that has_material_basis_in deficiency of the lysosomal acid alpha-glucosidase enzyme resulting in damage to muscle and nerve cells due to an accumulation of glycogen in the lysosome.] |
| LC50 | BAO_0002145 | [It is 50% lethal concentration (the concentration that kills 50% of treated cells).] |
| MIC | BAO_0002146 | [The lowest concentration of an inhibitor (antimicrobial agent) required to inhibit the growth of a microorganism.] |
| percent bound | BAO_0002147 | [It is a measure of the amount of radioligand that binds to its receptor in a competitive binding assay. It is the ratio of the bound to the total bound, where bound refers to the reading obtained from a binding reaction involving radioligand, receptor and a cold competitor ligand, while total bound is the reading obtained in the absence of any added competitor.] |
| Mycobacterium avium complex disease | DOID_2755 | [A primary bacterial infectious disease that results_in infection, has_material_basis_in Mycobacterium avium complex (MAC), which is transmitted_by inhalation or transmitted_by ingestion of via the respiratory or gastrointestinal tract respectively. The bacteria cause disseminated infection in HIV infected people, while pulmonary disease in immunocompetent persons.] |
| percent recovery | BAO_0002148 | [In a purification assay, percent recovery is the ratio of mass of the entity obtained after the affinity purification to the mass of the unpurified entity originally added in the assay, multiplied by 100.] |
| corneal ectasia | DOID_1436 | |
| brachydactyly | DOID_0050581 | [A dysostosis characterized by short fingers and toes.] |
| z-score normalization | BAO_0002160 | |
| mad-score normalization | BAO_0002161 |